Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer (Q33690321)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

hypermethylation

1 reference

based on heuristic

inferred from title

Kenneth P Nephew

17

object named as

Kenneth P Nephew

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Jian-Liang Chou

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Her-Young Su

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Lin-Yu Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yu-Ping Liao

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Corinna Hartman-Frey

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yi-Hui Lai

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Hui-Wen Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Daniel E Deatherage

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Chieh-Ti Kuo

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yi-Wen Huang

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Pearlly S Yan

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Shu-Huei Hsiao

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Chien-Kuo Tai

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Huey-Jen L Lin

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ramana V Davuluri

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Tai-Kuang Chao

16

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Tim H-M Huang

18

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Hung-Cheng Lai

19

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Michael W-Y Chan

20

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

11 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

414-425

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Minireview: epigenetic changes in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Epigenetics and cancer without genomic instability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

The role of cytoreductive/debulking surgery in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Roles of the EZH2 histone methyltransferase in cancer epigenetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Epigenetic biomarkers for human cancer: the time is now.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Role of endocrine and growth factors on the ovarian surface epithelium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Histone modifications silence the GATA transcription factor genes in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Epigenetic regulation of ARHI in breast and ovarian cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Identification of ubiquitin ligases required for skeletal muscle atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2829100

21 June 2018

Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

Prognostic DNA methylation biomarkers in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

Quantitative detection of methylated SOCS-1 , a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.138

21 January 2018

Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20065949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20065949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG island methylator phenotype in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20065949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LABINVEST.2009.138

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33690321&oldid=2195650096"